---
document_datetime: 2023-09-21 20:21:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/besremi-epar-all-authorised-presentations_en.pdf
document_name: besremi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8787054
conversion_datetime: 2025-12-18 10:50:15.384719
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength      | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                 | Content (concentration)   | Pack size                    |
|------------------|-------------------|---------------|------------------------|---------------------------|-------------------------------------|---------------------------|------------------------------|
| EU/1/18/1352/001 | Besremi           | 250 µg/0.5 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.5 ml                    | 1 pre-filled pen + 2 needles |
| EU/1/18/1352/002 | Besremi           | 500 µg/0.5 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.5 ml                    | 1 pre-filled pen + 2 needles |
| EU/1/18/1352/003 | Besremi           | 250 µg/0.5 ml | Solution for injection | Subcutaneous use          | cartridge (glass) in pre-filled pen | 0.5 ml                    | 3 pre-filled pen + 6 needles |